133 related articles for article (PubMed ID: 15917660)
1. Conditional EGFR promotes cell cycle progression and prevention of apoptosis in the absence of autocrine cytokines.
Shelton JG; Steelman LS; Abrams SL; White ER; Akula SM; Franklin RA; Bertrand FE; McMahon M; McCubrey JA
Cell Cycle; 2005 Jun; 4(6):822-30. PubMed ID: 15917660
[TBL] [Abstract][Full Text] [Related]
2. Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells.
McCubrey JA; Shelton JG; Steelman LS; Franklin RA; Sreevalsan T; McMahon M
Oncogene; 2004 Oct; 23(47):7810-20. PubMed ID: 15361836
[TBL] [Abstract][Full Text] [Related]
3. Effects of endogenous epidermal growth factor receptor signaling on DNA synthesis and ERK activation in a cytokine-dependent hematopoietic cell line.
Shelton JG; Steelman LS; Abrams SL; White ER; Akula SM; Bertrand FE; Franklin RA; McCubrey JA
Cell Cycle; 2005 Jun; 4(6):818-21. PubMed ID: 15908804
[TBL] [Abstract][Full Text] [Related]
4. Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells.
McCubrey JA; Steelman LS; Hoyle PE; Blalock WL; Weinstein-Oppenheimer C; Franklin RA; Cherwinski H; Bosch E; McMahon M
Leukemia; 1998 Dec; 12(12):1903-29. PubMed ID: 9844921
[TBL] [Abstract][Full Text] [Related]
5. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
6. Ability of the activated PI3K/Akt oncoproteins to synergize with MEK1 and induce cell cycle progression and abrogate the cytokine-dependence of hematopoietic cells.
Shelton JG; Blalock WL; White ER; Steelman LS; McCubrey JA
Cell Cycle; 2004 Apr; 3(4):503-12. PubMed ID: 15004527
[TBL] [Abstract][Full Text] [Related]
7. Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism.
Hoyle PE; Moye PW; Steelman LS; Blalock WL; Franklin RA; Pearce M; Cherwinski H; Bosch E; McMahon M; McCubrey JA
Leukemia; 2000 Apr; 14(4):642-56. PubMed ID: 10764150
[TBL] [Abstract][Full Text] [Related]
8. Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells.
Shelton JG; Steelman LS; Lee JT; Knapp SL; Blalock WL; Moye PW; Franklin RA; Pohnert SC; Mirza AM; McMahon M; McCubrey JA
Oncogene; 2003 Apr; 22(16):2478-92. PubMed ID: 12717425
[TBL] [Abstract][Full Text] [Related]
9. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
10. Cell death of MCF-7 human breast cancer cells induced by EGFR activation in the absence of other growth factors.
Garcia R; Franklin RA; McCubrey JA
Cell Cycle; 2006 Aug; 5(16):1840-6. PubMed ID: 16861904
[TBL] [Abstract][Full Text] [Related]
11. Chemical genetic blockade of transformation reveals dependence on aberrant oncogenic signaling.
Fan QW; Zhang C; Shokat KM; Weiss WA
Curr Biol; 2002 Aug; 12(16):1386-94. PubMed ID: 12194819
[TBL] [Abstract][Full Text] [Related]
12. Combination of sublethal concentrations of epidermal growth factor receptor inhibitor and microtubule stabilizer induces apoptosis of glioblastoma cells.
Failly M; Korur S; Egler V; Boulay JL; Lino MM; Imber R; Merlo A
Mol Cancer Ther; 2007 Feb; 6(2):773-81. PubMed ID: 17308073
[TBL] [Abstract][Full Text] [Related]
13. Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine dependency of human and murine hematopoietic cells.
Blalock WL; Moye PW; Chang F; Pearce M; Steelman LS; McMahon M; McCubrey JA
Leukemia; 2000 Jun; 14(6):1080-96. PubMed ID: 10865974
[TBL] [Abstract][Full Text] [Related]
14. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.
Wong MH; Xue A; Julovi SM; Pavlakis N; Samra JS; Hugh TJ; Gill AJ; Peters L; Baxter RC; Smith RC
Clin Cancer Res; 2014 Aug; 20(15):4047-58. PubMed ID: 24895459
[TBL] [Abstract][Full Text] [Related]
15. Synergy between Raf and BCL2 in abrogating the cytokine dependency of hematopoietic cells.
Moye PW; Blalock WL; Hoyle PE; Chang F; Franklin RA; Weinstein-Oppenheimer C; Pearce M; Steelman L; McMahon M; McCubrey JA
Leukemia; 2000 Jun; 14(6):1060-79. PubMed ID: 10865973
[TBL] [Abstract][Full Text] [Related]
16. Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines.
Vitiello PP; Cardone C; Martini G; Ciardiello D; Belli V; Matrone N; Barra G; Napolitano S; Della Corte C; Turano M; Furia M; Troiani T; Morgillo F; De Vita F; Ciardiello F; Martinelli E
J Exp Clin Cancer Res; 2019 Jan; 38(1):41. PubMed ID: 30691487
[TBL] [Abstract][Full Text] [Related]
17. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia.
Blalock WL; Navolanic PM; Steelman LS; Shelton JG; Moye PW; Lee JT; Franklin RA; Mirza A; McMahon M; White MK; McCubrey JA
Leukemia; 2003 Jun; 17(6):1058-67. PubMed ID: 12764369
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil elastase-initiated EGFR/MEK/ERK signaling counteracts stabilizing effect of autocrine TGF-beta on tropoelastin mRNA in lung fibroblasts.
DiCamillo SJ; Yang S; Panchenko MV; Toselli PA; Naggar EF; Rich CB; Stone PJ; Nugent MA; Panchenko MP
Am J Physiol Lung Cell Mol Physiol; 2006 Aug; 291(2):L232-43. PubMed ID: 16473861
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic Ha-Ras-dependent mitogen-activated protein kinase activity requires signaling through the epidermal growth factor receptor.
Hamilton M; Wolfman A
J Biol Chem; 1998 Oct; 273(43):28155-62. PubMed ID: 9774435
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic resistance in breast cancer cells can result from deregulated EGFR signaling.
Steelman LS; Chappell WH; Akula SM; Abrams SL; Cocco L; Manzoli L; Ratti S; Martelli AM; Montalto G; Cervello M; Libra M; Candido S; McCubrey JA
Adv Biol Regul; 2020 Dec; 78():100758. PubMed ID: 33022466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
